A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes

NCT06169982 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY3209590

Sponsor

Eli Lilly and Company